CRNX
CRNX
US22663K1079
Crinetics Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
9.01B EUR
--
--
--
Enterprise Value
7.85B EUR
--
--
--
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-20.63x
--
--
--
Price to Sales
213.8x
--
--
--
Price to Book
7.54x
--
--
--
EV/Revenue
186.25x
--
--
--
EV/EBITDA
-14.41x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.76%
--
--
--
ende